TCF National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.97M Sell
10,518
-2,008
-16% -$393K 0.22% 115
2020
Q4
$2.11M Buy
12,526
+131
+1% +$19.6K 0.22% 111
2020
Q3
$1.83M Buy
12,395
+2,808
+29% +$435K 0.22% 116
2020
Q2
$1.06M Buy
9,587
+382
+4% +$58.6K 0.12% 174
2020
Q1
$1.28M Sell
9,205
-265
-3% -$36.4K 0.19% 127
2019
Q4
$1.25M Buy
9,470
+160
+2% +$18.5K 0.14% 156
2019
Q3
$1.04M Buy
+9,310
New +$1.04M 0.13% 182

Other funds holding LLY

TCF National Bank's LLY Position: Q1 2021 in Review

TCF National Bank reduced its Eli Lilly (LLY) stake by 16% in Q1 2021, selling an estimated $393K and leaving 10,518 shares worth $1.97M. The position accounts for 0.22% of the portfolio, ranked #115.

TCF National Bank first reported a position in LLY in Q3 2019 and has held it in 7 quarters since. The position peaked at $2.11M in Q4 2020. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • TCF National Bank held 10,518 shares of Eli Lilly worth $1.97M as of Q1 2021.
  • TCF National Bank sold 2,008 Eli Lilly shares in Q1 2021, an estimated $393K.
  • Eli Lilly made up 0.22% of TCF National Bank's portfolio in Q1 2021, its #115 holding.
  • TCF National Bank first reported a position in Eli Lilly in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Eli Lilly position peaked at $2.11M in Q4 2020.
  • 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.